Humana's stock has shown resilience, boosted by a 5% increase in Medicare Advantage payments. Read my analysis of HUM stock.

Guggenheim analyst Jason Cassorla initiated coverage of Humana (HUM) with a Buy rating and $326 price target The firm launched coverage on 11 ...

UnitedHealth Group Incorporated UNH and Humana Inc. HUM are two of the most prominent players in the U.S. health insurance ...

The CMS announced a 5.06% expected average change in revenue for 2026 Medicare ... of pressure on many insurance stocks last year. But Humana Inc.'s stock (HUM) rose more than 11% in Monday's ...

We came across a long thesis on Humana Inc (NYSE:HUM ... from seniors returning to healthcare post-COVID, as well as changes to risk coding intensity (V28), which represents a short-term ...

Humana Inc. lost an administrative appeal in its ongoing battle to reverse changes to Medicare quality ratings that threaten ...

In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on Humana (HUM – Research Report), with a price target of ...

Harbour Investments Inc.’s holdings in Humana were worth $80,000 as of its most recent SEC filing. A number of other hedge funds also recently bought and sold shares of HUM.

Humana Stock Down 2.4 % Shares of NYSE HUM opened at $263.95 on Monday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a market cap ...